The president of Racing Commissioners International (RCI) said June 5 a survey of United States racing regulatory jurisdictions shows the adoption of the organization’s uniform medication policy for racing is advancing in every region of the country.

"Adoption of the ‘RCI Schedule of Controlled Therapeutic Substances’ is advancing through the regulatory processes of jurisdictions throughout the United States," said Ed Martin, RCI president, in a release. "This is national in scope and something that has eluded us all for a long time," he noted. "I know of no jurisdiction with the ability to enact these reforms that has refused to advance consideration leading to implementation of the schedule we added to the Model Rules in April."

Martin indicated established policies to ensure compliance with individual state administrative procedure statutes will govern the process of review and adoption in each racing regulatory jurisdiction.

"These reforms will be put out for public comment and it is important for the racing industry to unite and advocate for their adoption," he said